Literature DB >> 25344527

IL-1β-releasing human acute myeloid leukemia blasts modulate natural killer cell differentiation from CD34+ precursors.

Chiara Vitale1, Paolo Ambrosini2, Elisa Montaldo2, Filippo Ballerini3, Lorenzo Moretta4, Maria Cristina Mingari3.   

Abstract

Entities:  

Keywords:  CD34+ precursors; acute myeloid leukemia; natural killer cell

Mesh：

Substances：

Year:  2014        PMID： 25344527      PMCID： PMC4803123          DOI： 10.3324/haematol.2014.110494

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor.

Authors:  Elisa Montaldo; Chiara Vitale; Francesca Cottalasso; Romana Conte; Timor Glatzer; Paolo Ambrosini; Lorenzo Moretta; Maria Cristina Mingari
Journal:  Blood       Date:  2012-03-07       Impact factor: 22.113

Review 2.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia.

Authors:  Steven M Kornblau; David McCue; Neera Singh; Wenjing Chen; Zeev Estrov; Kevin R Coombes
Journal:  Blood       Date:  2010-08-02       Impact factor: 22.113

Review 4.  Location and cellular stages of natural killer cell development.

Authors:  Jianhua Yu; Aharon G Freud; Michael A Caligiuri
Journal:  Trends Immunol       Date:  2013-09-19       Impact factor: 16.687

5.  Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia.

Authors:  Régis T Costello; Simona Sivori; Emanuela Marcenaro; Marina Lafage-Pochitaloff; Marie-Joelle Mozziconacci; Denis Reviron; Jean-Albert Gastaut; Daniela Pende; Daniel Olive; Alessandro Moretta
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

Review 6.  Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation.

Authors:  Lorenzo Moretta; Franco Locatelli; Daniela Pende; Emanuela Marcenaro; Maria Cristina Mingari; Alessandro Moretta
Journal:  Blood       Date:  2010-10-01       Impact factor: 22.113

Review 7.  Development of human natural killer cells and other innate lymphoid cells.

Authors:  Elisa Montaldo; Paola Vacca; Lorenzo Moretta; Maria Cristina Mingari
Journal:  Semin Immunol       Date:  2014-02-18       Impact factor: 11.130

Review 8.  The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology.

Authors:  Antonio Curti; Sara Trabanelli; Valentina Salvestrini; Michele Baccarani; Roberto M Lemoli
Journal:  Blood       Date:  2008-11-20       Impact factor: 22.113

Review 9.  Contribution of bone microenvironment to leukemogenesis and leukemia progression.

Authors:  F Ayala; R Dewar; M Kieran; R Kalluri
Journal:  Leukemia       Date:  2009-09-03       Impact factor: 11.528

10.  Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells.

Authors:  Franco Locatelli; Daniela Pende; Maria C Mingari; Alice Bertaina; Michela Falco; Alessandro Moretta; Lorenzo Moretta
Journal:  Front Immunol       Date:  2013-02-01       Impact factor: 7.561
View more
  6 in total

Review 1.  NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation.

Authors:  Paola Vacca; Elisa Montaldo; Daniele Croxatto; Francesca Moretta; Alice Bertaina; Chiara Vitale; Franco Locatelli; Maria Cristina Mingari; Lorenzo Moretta
Journal:  Front Immunol       Date:  2016-05-18       Impact factor: 7.561

Review 2.  Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies.

Authors:  Elisa Zaghi; Michela Calvi; Clara Di Vito; Domenico Mavilio
Journal:  Front Immunol       Date:  2019-11-28       Impact factor: 7.561

3.  EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34+ Cells.

Authors:  Laura Damele; Adriana Amaro; Alberto Serio; Silvia Luchetti; Ulrich Pfeffer; Maria Cristina Mingari; Chiara Vitale
Journal:  Cancers (Basel)       Date:  2021-01-16       Impact factor: 6.639

4.  Immune reconstitution after T-cell replete HLA haploidentical hematopoietic stem cell transplantation using high-dose post-transplant cyclophosphamide.

Authors:  Yoshinobu Maeda
Journal:  J Clin Exp Hematop       Date:  2021-02-06

Review 5.  Stem Cell Therapy and Innate Lymphoid Cells.

Authors:  Divya Verma; Mukesh Verma; Rangnath Mishra
Journal:  Stem Cells Int       Date:  2022-08-02       Impact factor: 5.131

Review 6.  Targeted Therapies: Friends or Foes for Patient's NK Cell-Mediated Tumor Immune-Surveillance?

Authors:  Laura Damele; Selene Ottonello; Maria Cristina Mingari; Gabriella Pietra; Chiara Vitale
Journal:  Cancers (Basel)       Date:  2020-03-25       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.